← Home
The Doctor's Farmacy · June 29, 2026 · 29m

Encore: Why Normal Cholesterol Doesn't Always Mean Low Heart Disease Risk

Mark Hyman revisits his evolving view on heart disease, explaining that cholesterol is only part of the story. He highlights how ApoB, lipoprotein(a), inflammation, and insulin resistance are more important predictors of cardiovascular risk than total cholesterol. This encore episode covers the role of sugar and refined carbohydrates in driving inflammation, and shares personalized strategies for reducing risk through nutrition, lifestyle, and advanced testing.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Canon

Mark Hyman explains that standard cholesterol panels fail to identify many people at risk because ApoB particle number and lipoprotein(a) are more accurate predictors of arterial disease.
Hyman contends that heart disease is largely driven by insulin resistance, chronic inflammation, and metabolic dysfunction, not just cholesterol.

Highlights

Personalized Biomarker Testing Reveals Hidden Heart Disease Risk
Two people with identical total cholesterol numbers can have vastly different cardiovascular risk because standard tests miss crucial markers like inflammation and insulin sensitivity.

Editorial

Actionable Nutrition and Lifestyle Strategies to Lower Cardiovascular Risk
Hyman outlines a root-cause approach using nutrition, exercise, and targeted testing to reduce inflammation and improve metabolic health.

Misc

Mark Hyman states that he 'changed my mind' after decades of focusing primarily on cholesterol, now emphasizing metabolic and inflammatory root causes.
Was this useful?